Search research articles
Contact Us
Filters
Showing results (41-50 of 131) with videos related to
Page
of 14
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy
|
July 12, 2020
2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations
Michel Zeitouni, Pierre Sabouret, Mathieu Kerneis, et al.
Panminerva Medica
|
October 12, 2022
Lipid-lowering treatment up to one year after acute coronary syndrome: guidance from a French expert panel for the implementation of guidelines in practice
Pierre Sabouret, Etienne Puymirat, Serge Kownator, et al.
Journal of the Neurological Sciences
|
June 11, 2026
Reply to: "On interpreting treatment hierarchy following ischemic stroke in patients with atrial fibrillation and atherosclerotic cardiovascular disease"
Ahmed Ibrahim, Elsayed Balbaa, Ameer Awashra, et al.
Archives of Cardiovascular Diseases
|
June 27, 2015
Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey
Pierre Sabouret, Marie Bricard, Marie-Annick Hermann, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
May 14, 2020
The interplay between cardiology and diabetology: a renewed collaboration to optimize cardiovascular prevention and heart failure management
Pierre Sabouret, Giuseppe Galati, Denis Angoulvant, et al.
Journal of the Neurological Sciences
|
March 9, 2026
Optimal antithrombotic therapy for post-ischemic stroke patients with atrial fibrillation and atherosclerotic cardiovascular disease: A frequentist network meta-analysis
Ahmed Ibrahim, Elsayed Balbaa, Ameer Awashra, et al.
Archives of Cardiovascular Diseases
|
November 16, 2010
Observational study of adherence to European clinical practice guidelines for the management of acute coronary syndrome in revascularized versus non-revascularized patients - the CONNECT Study
Pierre Sabouret, Philippe Asseman, Jean Dallongeville, et al.
Panminerva Medica
|
April 6, 2023
French expert group proposal for lipid-lowering therapy in the first 3 months after acute myocardial infarction
François Schiele, Pierre Sabouret, Etienne Puymirat, et al.
Journal of the Neurological Sciences
|
May 8, 2026
Reply to letter to the editor regarding "Optimal antithrombotic therapy for post-ischemic stroke patients with atrial fibrillation and atherosclerotic cardiovascular disease: A frequentist network meta-analysis"
Ahmed Ibrahim, Elsayed Balbaa, Ameer Awashra, et al.
Expert Review of Cardiovascular Therapy
|
March 19, 2026
Percutaneous coronary intervention in high bleeding risk patients: a review of contemporary management strategies
Giuseppe Andò, Giulia Cavolina, Alessio Villari, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 131) with videos related to
Sort By:
Page
of 14
European Heart Journal. Cardiovascular Pharmacotherapy
|
July 12, 2020
2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations
Michel Zeitouni, Pierre Sabouret, Mathieu Kerneis, et al.
Panminerva Medica
|
October 12, 2022
Lipid-lowering treatment up to one year after acute coronary syndrome: guidance from a French expert panel for the implementation of guidelines in practice
Pierre Sabouret, Etienne Puymirat, Serge Kownator, et al.
Journal of the Neurological Sciences
|
June 11, 2026
Reply to: "On interpreting treatment hierarchy following ischemic stroke in patients with atrial fibrillation and atherosclerotic cardiovascular disease"
Ahmed Ibrahim, Elsayed Balbaa, Ameer Awashra, et al.
Archives of Cardiovascular Diseases
|
June 27, 2015
Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey
Pierre Sabouret, Marie Bricard, Marie-Annick Hermann, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
May 14, 2020
The interplay between cardiology and diabetology: a renewed collaboration to optimize cardiovascular prevention and heart failure management
Pierre Sabouret, Giuseppe Galati, Denis Angoulvant, et al.
Journal of the Neurological Sciences
|
March 9, 2026
Optimal antithrombotic therapy for post-ischemic stroke patients with atrial fibrillation and atherosclerotic cardiovascular disease: A frequentist network meta-analysis
Ahmed Ibrahim, Elsayed Balbaa, Ameer Awashra, et al.
Archives of Cardiovascular Diseases
|
November 16, 2010
Observational study of adherence to European clinical practice guidelines for the management of acute coronary syndrome in revascularized versus non-revascularized patients - the CONNECT Study
Pierre Sabouret, Philippe Asseman, Jean Dallongeville, et al.
Panminerva Medica
|
April 6, 2023
French expert group proposal for lipid-lowering therapy in the first 3 months after acute myocardial infarction
François Schiele, Pierre Sabouret, Etienne Puymirat, et al.
Journal of the Neurological Sciences
|
May 8, 2026
Reply to letter to the editor regarding "Optimal antithrombotic therapy for post-ischemic stroke patients with atrial fibrillation and atherosclerotic cardiovascular disease: A frequentist network meta-analysis"
Ahmed Ibrahim, Elsayed Balbaa, Ameer Awashra, et al.
Expert Review of Cardiovascular Therapy
|
March 19, 2026
Percutaneous coronary intervention in high bleeding risk patients: a review of contemporary management strategies
Giuseppe Andò, Giulia Cavolina, Alessio Villari, et al.
Page
of 14